Convelo Therapeutics is committed to developing medicines to regenerate myelin around nerve cells and restoring function to patients with neurological disorders.

The company was founded in 2016 by Case Western Reserve University School of Medicine professors Paul Tesar, Ph.D. and Drew Adams, Ph.D. to translate discoveries from their laboratories into medicines for critically ill patients. They were joined by biotech veteran Steven Landau, MD.

Industry Sector
Biomedical & Health Tech

Founded
2016

JumpStart Investment
Evergreen Fund